Joe Biden applauds Novo Nordisk for insulin price reductions
The US president urges more companies to follow suit after Novo Nordisk and Eli Lilly say they will lower insulin list prices.
by marketwire, translated by daniel pedersen
Danish Drugmaker Novo Nordisk is receiving praise from US President Joe Biden for the company’s plans to reduce list prices on a number of older insulin products, reports Bloomberg News.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk to reduce insulin prices by up to 75% in the US
For subscribers
.jpg)
.jpg&w=384&q=75)
